Cargando…

Advanced Activity-Based Protein Profiling Application Strategies for Drug Development

Drug targets and modes of action remain two of the biggest challenges in drug development. To address these problems, chemical proteomic approaches have been introduced to profile targets in complex proteomes. Activity-based protein profiling (ABPP) is one of a growing number chemical proteomic appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shan, Tian, Yu, Wang, Min, Sun, Gui-bo, Sun, Xiao-bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900428/ https://www.ncbi.nlm.nih.gov/pubmed/29686618 http://dx.doi.org/10.3389/fphar.2018.00353

Ejemplares similares

Targets Fishing and Identification of Calenduloside E as Hsp90AB1: Design, Synthesis, and Evaluation of Clickable Activity-Based Probe
por: Wang, Shan, et al.
Publicado: (2018)

Myricitrin Protects Cardiomyocytes from Hypoxia/Reoxygenation Injury: Involvement of Heat Shock Protein 90
por: Wang, Min, et al.
Publicado: (2017)

Salvianolic Acid A Ameliorates Arsenic Trioxide-Induced Cardiotoxicity Through Decreasing Cardiac Mitochondrial Injury and Promotes Its Anticancer Activity
por: Zhang, Jing-yi, et al.
Publicado: (2018)

Calenduloside E Analogues Protecting H9c2 Cardiomyocytes Against H(2)O(2)-Induced Apoptosis: Design, Synthesis and Biological Evaluation
por: Tian, Yu, et al.
Publicado: (2017)

Ginsenoside Compound K Attenuates Ox-LDL-Mediated Macrophage Inflammation and Foam Cell Formation via Autophagy Induction and Modulating NF-κB, p38, and JNK MAPK Signaling
por: Lu, Shan, et al.
Publicado: (2020)

Current Strategies and Applications for Precision Drug Design
por: Wang, Chen, et al.
Publicado: (2018)

Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury
por: He, Xian, et al.
Publicado: (2022)

Editorial: Advances in drug-induced diseases
por: Liu, Yao, et al.
Publicado: (2023)

Advances in Drug Delivery via Biodegradable Ureteral Stent for the Treatment of Upper Tract Urothelial Carcinoma
por: Shan, Hongli, et al.
Publicado: (2020)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
por: Wang, Peile, et al.
Publicado: (2020)

Real-Life Experience of Regorafenib in Patients With Advanced Hepatocellular Carcinoma
por: Hou, Jing-Yu, et al.
Publicado: (2022)

Integrated Random Negative Sampling and Uncertainty Sampling in Active Learning Improve Clinical Drug Safety Drug–Drug Interaction Information Retrieval
por: Xie, Weixin, et al.
Publicado: (2021)

Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
por: Liu, Xiao-Huan, et al.
Publicado: (2022)

The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non–small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials
por: Wang, Cheng-Qiong, et al.
Publicado: (2021)

Quantitative phenotypic and pathway profiling guides rational drug combination strategies
por: Dawson, John C., et al.
Publicado: (2014)

DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins
por: Gong, Yuxin, et al.
Publicado: (2021)

Characterization of Alpelisib in Rat Plasma by a Newly Developed UPLC-MS/MS Method: Application to a Drug-Drug Interaction Study
por: Wang, Qiong, et al.
Publicado: (2021)

Chinmedomics Strategy for Elucidating the Pharmacological Effects and Discovering Bioactive Compounds From Keluoxin Against Diabetic Retinopathy
por: Kong, Ling, et al.
Publicado: (2022)

Advances in Chemical Constituents, Clinical Applications, Pharmacology, Pharmacokinetics and Toxicology of Erigeron breviscapus
por: Wu, Ruixia, et al.
Publicado: (2021)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018)

Recent Advances in Nano-Therapeutic Strategies for Osteoarthritis
por: Guo, Xinjing, et al.
Publicado: (2022)

Advances in natural products and antibody drugs for SLE: new therapeutic ideas
por: Han, Yibing, et al.
Publicado: (2023)

Salvia miltiorrhiza Bge. (Danshen) for Inflammatory Bowel Disease: Clinical Evidence and Network Pharmacology-Based Strategy for Developing Supplementary Medical Application
por: Zhang, Siyuan, et al.
Publicado: (2022)

New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022
por: Jiang, JingSi, et al.
Publicado: (2022)

Advances in the Application of Natural Products and the Novel Drug Delivery Systems for Psoriasis
por: Xie, Jin, et al.
Publicado: (2021)

Development of a Multi-Target Strategy for the Treatment of Vitiligo via Machine Learning and Network Analysis Methods
por: Wang, Jiye, et al.
Publicado: (2021)

An Entire Process Optimization Strategy for Comprehensive In Vivo Metabolite Profiling of Prucalopride in Rats Based on Ultra-Performance Liquid Chromatography With Q-Exactive Hybrid Quadrupole–Orbitrap High-Resolution Mass Spectrometry
por: Zuo, Lihua, et al.
Publicado: (2021)

Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform
por: Cui, Fengzhi, et al.
Publicado: (2022)

Nanosystems for chemodynamic based combination therapy: Strategies and recent advances
por: Li, Minghui, et al.
Publicado: (2022)

Cytochrome P450 3A Enzymes Are Key Contributors for Hepatic Metabolism of Bufotalin, a Natural Constitute in Chinese Medicine Chansu
por: Dai, Zi-Ru, et al.
Publicado: (2019)

Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA
por: Ge, Xuemei, et al.
Publicado: (2021)

Research advances in treatment methods and drug development for rare diseases
por: Han, Qiaoqiao, et al.
Publicado: (2022)

Effects of Maren Pills on the Intestinal Microflora and Short-Chain Fatty Acid Profile in Drug-Induced Slow Transit Constipation Model Rats
por: Zhan, Yu, et al.
Publicado: (2022)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
por: Zeng, Ying, et al.
Publicado: (2019)

Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae
por: Ji, Xi-Wei, et al.
Publicado: (2022)

Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis
por: Lu, Junjie, et al.
Publicado: (2022)

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis
por: Wang, Jiaying, et al.
Publicado: (2019)

Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qgtukr61jk8kajubvm69hnvl20